As reported in Table 1, no statistically significant differences were observed concerning sex, BMI, MAP, presence of arterial hypertension, ischemic heart disease, treatment with ACE-inhibitors, or RAAS-inhibitors, bilirubin values, platelet count, fibrinogen levels, the presence of DVT signs (assessed by CUS or CT), and treatment with anticoagulants. The gene discussed is ACE; the disease is coronary artery disorder.